BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher‐stine L, Crow‐hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2020;72:529-56. [DOI: 10.1002/art.41191] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Imazio M, Lazaros G, Gattorno M, LeWinter M, Abbate A, Brucato A, Klein A. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists. Eur Heart J 2021:ehab452. [PMID: 34528670 DOI: 10.1093/eurheartj/ehab452] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li X, Shopit A, Wang J. Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update. Arch Gynecol Obstet 2021. [PMID: 34390384 DOI: 10.1007/s00404-021-06178-5] [Reference Citation Analysis]
3 Maguire S, Wilson F, Gallagher P, Mohamed MM, Maher S, O'shea F. What to Expect when Women with Axial Spondyloarthritis are Expecting: Prevalence of Complications of Pregnancies in Women with Axial Spondyloarthritis. Seminars in Arthritis and Rheumatism 2022. [DOI: 10.1016/j.semarthrit.2022.151993] [Reference Citation Analysis]
4 Islabão AG, Trindade VC, da Mota LMH, Andrade DCO, Silva CA. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects. Paediatr Drugs 2021. [PMID: 34904182 DOI: 10.1007/s40272-021-00484-w] [Reference Citation Analysis]
5 Hudson M, Ghossein C, Steen V. Scleroderma renal crisis. Presse Med 2021;50:104063. [PMID: 33548376 DOI: 10.1016/j.lpm.2021.104063] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Lopalco G, Rigante D, Lopalco A, Emmi G, Venerito V, Vitale A, Capozio G, Denora N, Cantarini L, Iannone F. Safety of systemic treatments for Behçet's syndrome. Expert Opin Drug Saf 2020;19:1269-301. [PMID: 32883123 DOI: 10.1080/14740338.2020.1817379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Silverstein RG, Fitz V, Thornton M, Carter A, Morse JE. Contraceptive use and counseling in patients with systemic lupus erythematosus. Contraception 2022;105:46-50. [PMID: 34492256 DOI: 10.1016/j.contraception.2021.08.017] [Reference Citation Analysis]
8 Pastick KA, Nicol MR, Smyth E, Zash R, Boulware DR, Rajasingham R, McDonald EG. A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials. Open Forum Infect Dis 2020;7:ofaa350. [PMID: 32929403 DOI: 10.1093/ofid/ofaa350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
9 Fischer-Betz R, Østensen M. Biologics and small molecules in the management of psoriatic arthritis: Reproduction related issues in female and male patients. Expert Rev Clin Pharmacol 2021;14:979-89. [PMID: 33982647 DOI: 10.1080/17512433.2021.1925536] [Reference Citation Analysis]
10 Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome. Front Med (Lausanne) 2021;8:730161. [PMID: 34552948 DOI: 10.3389/fmed.2021.730161] [Reference Citation Analysis]
11 Chakrabarti K, McCune WJ. Advances in the clinical use of hydroxychloroquine levels. Curr Opin Rheumatol 2022;34:151-7. [PMID: 35440530 DOI: 10.1097/BOR.0000000000000872] [Reference Citation Analysis]
12 Rebić N, Munro S, Garg R, Hazlewood G, Amiri N, Baldwin C, Ensworth S, Proulx L, De Vera MA. “The medications are the decision-makers…” Making reproductive and medication use decisions among female patients with rheumatoid arthritis: a constructivist grounded theory. Arthritis Res Ther 2022;24. [DOI: 10.1186/s13075-021-02704-7] [Reference Citation Analysis]
13 Ganhão S, Fredi M, Barbieri S, Orellana-Gonzalez M, Polastri G, Zatti S, Franceschini F, Tincani A, Sartori E, Prefumo F, Andreoli L, Fichera A. Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study. Eur J Obstet Gynecol Reprod Biol 2021;264:49-55. [PMID: 34271365 DOI: 10.1016/j.ejogrb.2021.06.043] [Reference Citation Analysis]
14 Pregnolato F, Gerosa M, Raimondo MG, Comerio C, Bartoli F, Lonati PA, Borghi MO, Acaia B, Ossola MW, Ferrazzi E, Trespidi L, Meroni PL, Chighizola CB. EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies. Rheumatology (Oxford) 2021;60:1114-24. [PMID: 32441742 DOI: 10.1093/rheumatology/keaa203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
15 Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Rheum Dis Clin North Am 2022;48:523-35. [PMID: 35400376 DOI: 10.1016/j.rdc.2022.02.009] [Reference Citation Analysis]
16 Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø. Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. J Neurol 2020. [PMID: 33011853 DOI: 10.1007/s00415-020-10235-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Capone F, Albanese A, Quadri G, Di Lazzaro V, Falato E, Cortese A, De Giglio L, Ferraro E. Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review. Front Neurol 2022;13:851413. [DOI: 10.3389/fneur.2022.851413] [Reference Citation Analysis]
18 Njagu R, Criscione-Schreiber LG, Eudy A, Snyderman A, Clowse MEB. Impact of a Multifaceted Educational Program to Improve Provider Skills for Lupus Pregnancy Planning and Management: A Mixed-Methods Approach. ACR Open Rheumatol 2020;2:378-87. [PMID: 32485074 DOI: 10.1002/acr2.11147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lockshin MD, Guerra M, Salmon JE. Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases. Arthritis Rheumatol 2020;72:1325-9. [PMID: 32162838 DOI: 10.1002/art.41249] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Fayet F, Pereira B, Fan A, Rodere M, Savel C, Berland P, Soubrier M, Tournadre A, Dubost JJ. Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study. Rheumatol Int 2021. [PMID: 34050794 DOI: 10.1007/s00296-021-04893-5] [Reference Citation Analysis]
21 Genovese G, Derlino F, Berti E, Marzano AV. Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation: A Review Focusing on Pemphigus and Pemphigoid Gestationis. Front Pharmacol 2020;11:583354. [PMID: 33117178 DOI: 10.3389/fphar.2020.583354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ono M, Matsumoto K, Boku N, Fujii N, Tsuchida Y, Furui T, Harada M, Kanda Y, Kawai A, Miyachi M, Murashima A, Nakayama R, Nishiyama H, Shimizu C, Sugiyama K, Takai Y, Fujio K, Morishige KI, Osuga Y, Suzuki N. Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases. Int J Clin Oncol 2021. [PMID: 34791542 DOI: 10.1007/s10147-021-02082-9] [Reference Citation Analysis]
23 Udupa A, Leverenz D, Balevic SJ, Sadun RE, Tarrant TK, Rogers JL. Hydroxychloroquine and COVID-19: a Rheumatologist's Take on the Lessons Learned. Curr Allergy Asthma Rep 2021;21:5. [PMID: 33475900 DOI: 10.1007/s11882-020-00983-9] [Reference Citation Analysis]
24 Aringer M, Alarcón-riquelme ME, Clowse M, Pons-estel GJ, Vital EM, Dall’era M. A glimpse into the future of systemic lupus erythematosus. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2210867. [DOI: 10.1177/1759720x221086719] [Reference Citation Analysis]
25 Buasawat P, Manonai J, Ngamjanyaporn P. Perception of contraceptive counseling and contraceptive use among systemic lupus erythematosus patients. Contraception 2021;103:38-43. [PMID: 33130108 DOI: 10.1016/j.contraception.2020.10.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Connelly K, Morand EF. Systemic lupus erythematosus: a clinical update. Intern Med J 2021;51:1219-28. [PMID: 34423550 DOI: 10.1111/imj.15448] [Reference Citation Analysis]
27 Essouma M, Nkeck JR, Motolouze K, Bigna JJ, Tchaptchet P, Nkoro GA, Ralandison S, Hachulla E. Outcomes of pregnancy and associated factors in sub-Saharan African women with systemic lupus erythematosus: a scoping review. Lupus Sci Med 2020;7:e000400. [PMID: 32540928 DOI: 10.1136/lupus-2020-000400] [Reference Citation Analysis]
28 Morel J, Tournadre A, Sellam J, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C. Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105221. [PMID: 34183155 DOI: 10.1016/j.jbspin.2021.105221] [Reference Citation Analysis]
29 Chimenti MS, Alten R, D'Agostino MA, Gremese E, Kiltz U, Lubrano E, Moreno M, Pham T, Ramonda R, Spinelli FR, Perella C, Andreoli L. Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients. RMD Open 2021;7:e001681. [PMID: 34876490 DOI: 10.1136/rmdopen-2021-001681] [Reference Citation Analysis]
30 Meißner Y, Strangfeld A. [Insights into pregnancy and breastfeeding in inflammatory rheumatic diseases through observational data]. Z Rheumatol 2021;80:733-42. [PMID: 34535821 DOI: 10.1007/s00393-021-01082-4] [Reference Citation Analysis]
31 Crisafulli F, Tincani A, Franceschini F, Andreoli L. Women of childbearing age living with spondyloarthritis: time for improving knowledge and counselling about reproductive issues. Rheumatology (Oxford) 2021:keab857. [PMID: 34791099 DOI: 10.1093/rheumatology/keab857] [Reference Citation Analysis]
32 Samanta J, Mishra D, Chattopadhyay A, Dhir V. Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies. Rheumatology (Oxford) 2021;60:e109. [PMID: 32910815 DOI: 10.1093/rheumatology/keaa533] [Reference Citation Analysis]
33 Bérard A, Sheehy O, Zhao JP, Vinet E, Quach C, Bernatsky S. Chloroquine and Hydroxychloroquine Use During Pregnancy and the Risk of Adverse Pregnancy Outcomes Using Real-World Evidence. Front Pharmacol 2021;12:722511. [PMID: 34408654 DOI: 10.3389/fphar.2021.722511] [Reference Citation Analysis]
34 Kim JW, Jung JY, Kim HA, Yang JI, Kwak DW, Suh CH. Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients With Systemic Lupus Erythematosus. J Rheumatol 2021;48:707-16. [PMID: 33060317 DOI: 10.3899/jrheum.200802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Williams SG, Wolin SL. The Autoantigen Repertoire and the Microbial RNP World. Trends Mol Med 2021;27:422-35. [PMID: 33722441 DOI: 10.1016/j.molmed.2021.02.003] [Reference Citation Analysis]
36 Grosen A, Bellaguarda E, Liljeqvist-Soltic I, Mejlby Hansen M, Skytte AB, Julsgaard M, Hanauer SB, Kelsen J. Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy. Inflamm Bowel Dis 2022:izac028. [PMID: 35212374 DOI: 10.1093/ibd/izac028] [Reference Citation Analysis]
37 Haase I, Fischer-Betz R. [State of the art: fertility and pregnancy in rheumatic diseases]. Z Rheumatol 2021;80:699-706. [PMID: 34535818 DOI: 10.1007/s00393-021-01073-5] [Reference Citation Analysis]
38 Hellgren K, Secher AE, Glintborg B, Rom AL, Gudbjornsson B, Michelsen B, Granath F, Hetland ML. Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis. Rheumatology (Oxford) 2021:keab894. [PMID: 34864891 DOI: 10.1093/rheumatology/keab894] [Reference Citation Analysis]
39 Orlandi M, Vannuccini S, El Aoufy K, Melis MR, Lepri G, Sambataro G, Bellando-randone S, Guiducci S, Cerinic MM, Petraglia F. Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases. Front Pharmacol 2022;13:807880. [DOI: 10.3389/fphar.2022.807880] [Reference Citation Analysis]
40 Murata T, Kyozuka H, Fukuda T, Toba N, Kanno A, Yasuda S, Yamaguchi A, Nomura Y, Kanno T, Migita K, Fujimori K. Maternal disease activity and serological activity as predictors of adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective chart review. Arch Gynecol Obstet. [DOI: 10.1007/s00404-021-06148-x] [Reference Citation Analysis]
41 Rebić N, Garg R, Ellis U, Kitchin V, Munro S, Hazlewood G, Amiri N, Bansback N, De Vera MA. "Walking into the unknown…" key challenges of pregnancy and early parenting with inflammatory arthritis: a systematic review and thematic synthesis of qualitative studies. Arthritis Res Ther 2021;23:123. [PMID: 33882998 DOI: 10.1186/s13075-021-02493-z] [Reference Citation Analysis]
42 Carnovale C, Parisi F, Battini V, Zavatta A, Cheli S, Cattaneo D, Gringeri M, Mosini G, Guarnieri G, Cammarata G, Cetin I. The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacol Res 2021;171:105786. [PMID: 34314858 DOI: 10.1016/j.phrs.2021.105786] [Reference Citation Analysis]
43 Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2110730. [DOI: 10.1177/1759720x211073001] [Reference Citation Analysis]
44 Kohno C, Kaneko K, Takahashi K, Ohya Y, Nakajima H, Murashima A. Intrauterine exposure to immunosuppressants influences the development of postnatal allergic diseases. Allergy 2021. [PMID: 33905116 DOI: 10.1111/all.14878] [Reference Citation Analysis]
45 Kim J, Suh C. The Safety of Medications During Pregnancy and Lactation in Patients with Inflammatory Rheumatic Diseases. EMJ. [DOI: 10.33590/emj/21-00017] [Reference Citation Analysis]
46 Stransky OM, Wolgemuth T, Kazmerski T, Chodoff A, Borrero S, Birru Talabi M. Contraception decision-making and care among reproductive-aged women with autoimmune diseases. Contraception 2021;103:86-91. [PMID: 33181126 DOI: 10.1016/j.contraception.2020.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Tincani A, Andreoli L. A guide to managing reproductive health in rheumatology. Nat Rev Rheumatol 2020;16:411-2. [DOI: 10.1038/s41584-020-0443-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Anderson PO. Monoclonal Antibodies During Breastfeeding. Breastfeed Med 2021;16:591-3. [PMID: 33956488 DOI: 10.1089/bfm.2021.0110] [Reference Citation Analysis]
49 Konig MF, Gianfrancesco M, Yazdany J, Robinson PC. Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al. Ann Rheum Dis 2020:annrheumdis-2020-217990. [PMID: 32475834 DOI: 10.1136/annrheumdis-2020-217990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
50 Pham-Huy A, Top KA, Constantinescu C, Seow CH, El-Chaâr D. The use and impact of monoclonal antibody biologics during pregnancy. CMAJ 2021;193:E1129-36. [PMID: 34312166 DOI: 10.1503/cmaj.202391] [Reference Citation Analysis]
51 Murata T, Kyozuka H, Fukuda T, Yasuda S, Yamaguchi A, Sato A, Ogata Y, Kuse M, Hosoya M, Yasumura S, Hashimoto K, Nishigori H, Fujimori K; Japan Environment and Children’s Study Group. Risk of adverse obstetric outcomes in Japanese women with systemic lupus erythematosus: The Japan Environment and Children's Study. PLoS One 2020;15:e0233883. [PMID: 32470103 DOI: 10.1371/journal.pone.0233883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 García-Fernández A, Gerardi MC, Crisafulli F, Filippini M, Fredi M, Gorla R, Lazzaroni MG, Lojacono A, Nalli C, Ramazzotto F, Taglietti M, Zanardini C, Zatti S, Franceschini F, Tincani A, Andreoli L. Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic. Clin Rheumatol 2021;40:239-44. [PMID: 32945981 DOI: 10.1007/s10067-020-05404-w] [Reference Citation Analysis]
53 Mormile I, Granata F, Punziano A, de Paulis A, Rossi FW. Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It? Biomedicines 2021;9:132. [PMID: 33535377 DOI: 10.3390/biomedicines9020132] [Reference Citation Analysis]
54 Mills BS, Bermas BL. Improving Knowledge of Lactation Compatibility of Antirheumatic Medications Among Providers Who Care for Patients With Rheumatic Disease. ACR Open Rheumatol 2021;3:50-4. [PMID: 33393732 DOI: 10.1002/acr2.11214] [Reference Citation Analysis]
55 Lenormand C, Lipsker D. Lupus erythematosus: Significance of dermatologic findings. Ann Dermatol Venereol 2021;148:6-15. [PMID: 33483145 DOI: 10.1016/j.annder.2020.08.052] [Reference Citation Analysis]
56 Giles I, Allen A, Crossley A, Flint J, Frishman M, Gayed M, Kamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Wiliams D, Yee CS, Gordon C. Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scope. Rheumatology (Oxford) 2021;60:3565-9. [PMID: 33848327 DOI: 10.1093/rheumatology/keab334] [Reference Citation Analysis]
57 Patel S, Kumthekar A. Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. Rheumatol Ther 2021. [PMID: 34797530 DOI: 10.1007/s40744-021-00397-7] [Reference Citation Analysis]
58 Orefice V, Ceccarelli F, Pirone C, Galoppi P, Spinelli FR, Alessandri C, Brunelli R, Perrone G, Conti F. Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors. Lupus 2021;30:913-20. [PMID: 33611966 DOI: 10.1177/0961203321995263] [Reference Citation Analysis]
59 Foddai SG, Radin M, Cecchi I, Gaito S, Orpheu G, Rubini E, Barinotti A, Menegatti E, Mengozzi G, Roccatello D, Manetta T, Donati Marello B, Benedetto C, Marozio L, Sciascia S. The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities. J Thromb Haemost 2020;18:2921-8. [PMID: 32780559 DOI: 10.1111/jth.15053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Li X, Deng X, Duan H, Zeng L, Zhou J, Liu C, Guo X, Liu X. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study. Clin Rheumatol 2021;40:193-204. [PMID: 32514680 DOI: 10.1007/s10067-020-05203-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Nalli C, Galli J, Lini D, Merlini A, Piantoni S, Lazzaroni MG, Bitsadze V, Khizroeva J, Zatti S, Andreoli L, Fazzi E, Franceschini F, Makatsariya A, Shoenfeld Y, Tincani A. The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. Front Pharmacol 2021;12:626258. [PMID: 33815108 DOI: 10.3389/fphar.2021.626258] [Reference Citation Analysis]
62 Pagan ME, Ramseyer AM, Whitcombe DD, Doiron TE, Magann EF, Sandlin AT, Hughes DS. Management of Critically Ill Pregnant Patients with COVID-19 Infection in a Rural State. Am J Perinatol 2021. [PMID: 34775583 DOI: 10.1055/s-0041-1739292] [Reference Citation Analysis]
63 Ueda A, Chigusa Y, Mogami H, Kawasaki K, Horie A, Mandai M, Kondoh E. Predictive factors for flares of established stable systemic lupus erythematosus without anti-phospholipid antibodies during pregnancy. J Matern Fetal Neonatal Med 2020;:1-6. [PMID: 33143489 DOI: 10.1080/14767058.2020.1843626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Grygiel-Górniak B, Masiero E, Nevaneeth BC, Jojy MM. Rheumatic Diseases in Reproductive Age-the Possibilities and the Risks. Reprod Sci 2022. [PMID: 35359225 DOI: 10.1007/s43032-022-00901-6] [Reference Citation Analysis]
65 Chighizola CB, Pregnolato F. Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies: reply. Rheumatology (Oxford) 2021;60:e110-2. [PMID: 32910811 DOI: 10.1093/rheumatology/keaa539] [Reference Citation Analysis]
66 Kaneko K, Ozawa N, Murashima A. Obstetric anti-phospholipid syndrome: from pathogenesis to treatment. Immunol Med 2021;:1-15. [PMID: 34470570 DOI: 10.1080/25785826.2021.1969116] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Fierro JJ, Velásquez M, Cadavid AP, de Leeuw K. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome. Am J Reprod Immunol 2021;:e13509. [PMID: 34738282 DOI: 10.1111/aji.13509] [Reference Citation Analysis]
68 Bongenaar M, Smeele HTW, Lubberts E, Dolhain RJEM. IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive. Front Pharmacol 2020;11:604866. [PMID: 33362560 DOI: 10.3389/fphar.2020.604866] [Reference Citation Analysis]
69 Pham-Huy A, Top KA, Constantinescu C, Seow CH, El-Chaâr D. Utilisation et incidence des agents biologiques à base d’anticorps monoclonaux durant la grossesse. CMAJ 2021;193:E1537-44. [PMID: 34607850 DOI: 10.1503/cmaj.202391-f] [Reference Citation Analysis]
70 Nagy G, Roodenrijs NMT, Welsing PMJ, Kedves M, Hamar A, van der Goes MC, Kent A, Bakkers M, Pchelnikova P, Blaas E, Senolt L, Szekanecz Z, Choy EH, Dougados M, Jacobs JW, Geenen R, Bijlsma JW, Zink A, Aletaha D, Schoneveld L, van Riel P, Dumas S, Prior Y, Nikiphorou E, Ferraccioli G, Schett G, Hyrich KL, Mueller-Ladner U, Buch MH, McInnes IB, van der Heijde D, van Laar JM. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 2021:annrheumdis-2021-220973. [PMID: 34407926 DOI: 10.1136/annrheumdis-2021-220973] [Reference Citation Analysis]
71 Ruiz-Irastorza G, Martín-Iglesias D, Soto-Peleteiro A. Update on antimalarials and systemic lupus erythematosus. Curr Opin Rheumatol 2020;32:572-82. [PMID: 32890029 DOI: 10.1097/BOR.0000000000000743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
72 Zhang L, Chu CQ. Gut Microbiota-Medication Interaction in Rheumatic Diseases. Front Immunol 2021;12:796865. [PMID: 34925383 DOI: 10.3389/fimmu.2021.796865] [Reference Citation Analysis]
73 Kwak-kim J, Alsubki L, Luu T, Ganieva U, Thees A, Dambaeva S, Gilman-sachs A. The role of immunologic tests for subfertility in the clinical environment. Fertility and Sterility 2022. [DOI: 10.1016/j.fertnstert.2022.04.009] [Reference Citation Analysis]
74 Taulaigo AV, Moschetti L, Ganhão S, Gerardi MC, Franceschini F, Tincani A, Andreoli L. Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus. Expert Opin Drug Saf 2021;20:523-36. [PMID: 33599570 DOI: 10.1080/14740338.2021.1893298] [Reference Citation Analysis]
75 Dewarrat N, Gavillet M, Angelillo-Scherrer A, Naveiras O, Grandoni F, Tsakiris DA, Alberio L, Blum S. Acquired haemophilia A in the postpartum and risk of relapse in subsequent pregnancies: A systematic literature review. Haemophilia 2021;27:199-210. [PMID: 33550699 DOI: 10.1111/hae.14233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Carnovale C, Tombetti E, Battini V, Mazhar F, Radice S, Nivuori M, Negro E, Tamanini S, Brucato A. Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review.Front Pharmacol. 2020;11:612259. [PMID: 33551814 DOI: 10.3389/fphar.2020.612259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J 2021;42:2745-60. [PMID: 33961006 DOI: 10.1093/eurheartj/ehab221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
79 Birru Talabi M, Eudy AM, Jayasundara M, Haroun T, Nowell WB, Curtis JR, Crow-Hercher R, White W, Ginsberg S, Clowse MEB. Tough Choices: Exploring Medication Decision-Making During Pregnancy and Lactation Among Women With Inflammatory Arthritis. ACR Open Rheumatol 2021;3:475-83. [PMID: 34114738 DOI: 10.1002/acr2.11240] [Reference Citation Analysis]
80 Nara M, Kaga H, Saito M, Abe F, Saito A, Imaizumi C, Komatsuda A, Wakui H, Takahashi N. Successful Pregnancies in a Patient with Childhood-onset Steroid-dependent Nephrotic Syndrome during Rituximab Maintenance Therapy. Intern Med 2021;60:2985-9. [PMID: 33776000 DOI: 10.2169/internalmedicine.6633-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Scott R, Parker H, Mccartney S, Harrow P, Williams D, Giles I. Outcomes following biosimilar TNF inhibitors use for inflammatory-mediated immune disorders in pregnancy. Obstet Med. [DOI: 10.1177/1753495x211028779] [Reference Citation Analysis]
82 Grosen A, Bellaguarda E, Nersting J, Hvas CL, Liljeqvist-Soltic I, Stein A, Christensen LA, Ruderman EM, Brown CR, Schmiegelow K, Zhang JX, Kelsen J, Hanauer SB. Low-dose Methotrexate Therapy Does Not Affect Semen Parameters and Sperm DNA. Inflamm Bowel Dis 2021:izab205. [PMID: 34463329 DOI: 10.1093/ibd/izab205] [Reference Citation Analysis]
83 Duan J, Ma D, Wen X, Guo Q, Gao J, Zhang G, Xu K, Zhang L. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis. Lupus 2021;30:1163-74. [PMID: 33853420 DOI: 10.1177/09612033211007199] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Nakai T, Kitada A, Fukui S, Okada M. Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis. Lupus 2021;30:1415-26. [PMID: 34013819 DOI: 10.1177/09612033211016074] [Reference Citation Analysis]
85 Friedman DM, Kim M, Costedoat-Chalumeau N, Clancy R, Copel J, Phoon CK, Cuneo BF, Cohen R, Masson M, Wainwright BJ, Zahr N, Saxena A, Izmirly PM, Buyon JP. Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation. Circ Arrhythm Electrophysiol 2020;13:e008686. [PMID: 32907357 DOI: 10.1161/CIRCEP.120.008686] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
86 Lee EE, Jun JK, Lee EB. Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy. J Korean Med Sci 2021;36:e24. [PMID: 33496084 DOI: 10.3346/jkms.2021.36.e24] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Lou F, Qin H, He S, Li M, An X, Song L, Tong Y, Fan H. The Benefits of Breastfeeding Still Outweigh the Risks of COVID-19 Transmission. Front Med (Lausanne) 2021;8:703950. [PMID: 34568367 DOI: 10.3389/fmed.2021.703950] [Reference Citation Analysis]
88 Sant'Antonio E, Borsani O, Camerini C, Botta C, Santoro M, Allegra A, Siragusa S. Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy. Blood Rev 2021;:100903. [PMID: 34742614 DOI: 10.1016/j.blre.2021.100903] [Reference Citation Analysis]
89 Braga A, Barros T, Faria R, Marinho A, Rocha G, Farinha F, Neves E, Vasconcelos C, Braga J. Systemic Lupus Erythematosus and Pregnancy: a Portuguese Case-Control Study. Clin Rev Allergy Immunol 2021. [PMID: 34519994 DOI: 10.1007/s12016-021-08893-y] [Reference Citation Analysis]
90 Häfeli C, Förger F. [Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding]. Z Rheumatol 2021;80:716-25. [PMID: 34581874 DOI: 10.1007/s00393-021-01095-z] [Reference Citation Analysis]
91 Mokbel A, Lawson DO, Farrokhyar F. Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review. Clin Rheumatol 2021;40:3465-80. [PMID: 33464430 DOI: 10.1007/s10067-021-05588-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Med Clin North Am 2021;105:341-53. [PMID: 33589107 DOI: 10.1016/j.mcna.2020.10.002] [Reference Citation Analysis]
93 Del Porto F, Ferrero S, Cifani N, Sesti G, Proietta M. Antiphospholipid antibodies and idiopathic infertility. Lupus 2022;:9612033221076735. [PMID: 35073215 DOI: 10.1177/09612033221076735] [Reference Citation Analysis]
94 Karvonen-Gutierrez CA, Leis A. Impact of menopause on women with systemic lupus erythematosus. Maturitas 2021;154:25-30. [PMID: 34736577 DOI: 10.1016/j.maturitas.2021.09.004] [Reference Citation Analysis]
95 De Felice KM, Kane S. Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol 2021;148:661-7. [PMID: 34489011 DOI: 10.1016/j.jaci.2021.07.005] [Reference Citation Analysis]
96 Padiyar S, Manikuppam P, Kabeerdoss J, Rathore S, Danda D. Update on pregnancy in Takayasu arteritis-A narrative review. Int J Rheum Dis 2021;24:758-65. [PMID: 33870620 DOI: 10.1111/1756-185X.14109] [Reference Citation Analysis]
97 Nicol MR, Joshi A, Rizk ML, Sabato PE, Savic RM, Wesche D, Zheng JH, Cook J. Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection. Clin Pharmacol Ther 2020;108:1135-49. [PMID: 32687630 DOI: 10.1002/cpt.1993] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
98 Nikolopoulos D, Fotis L, Gioti O, Fanouriakis A. Tailored treatment strategies and future directions in systemic lupus erythematosus. Rheumatol Int 2022. [PMID: 35449237 DOI: 10.1007/s00296-022-05133-0] [Reference Citation Analysis]
99 Birru Talabi M, Himes KP, Clowse MEB. Optimizing reproductive health management in lupus and Sjogren's syndrome. Curr Opin Rheumatol 2021;33:570-8. [PMID: 34519280 DOI: 10.1097/BOR.0000000000000839] [Reference Citation Analysis]
100 Clowse M, Fischer-betz R, Nelson-piercy C, Scheuerle AE, Stephan B, Dubinsky M, Kumke T, Kasliwal R, Lauwerys B, Förger F. Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2210876. [DOI: 10.1177/1759720x221087650] [Reference Citation Analysis]
101 Fesler MC, Stricker RB. Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women. Int J Gen Med 2021;14:279-84. [PMID: 33542646 DOI: 10.2147/IJGM.S295627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
102 Mouyis M. Postnatal Care of Woman with Rheumatic Diseases. Adv Ther 2020;37:3723-31. [PMID: 32729009 DOI: 10.1007/s12325-020-01448-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Pires Da Rosa G, Rodríguez-Pintó I, Cervera R, Espinosa G. Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines. Expert Rev Hematol 2021;14:457-66. [PMID: 33909986 DOI: 10.1080/17474086.2021.1923474] [Reference Citation Analysis]
104 Polić A, Običan SG. Pregnancy in systemic lupus erythematosus. Birth Defects Res 2020;112:1115-25. [PMID: 32902202 DOI: 10.1002/bdr2.1790] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]